Lipoprotein (a) Concentrations in Patients with Various Dyslipidaemias

References

• Utermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904–10
   PubMed Web of Science ®Google Scholar
• Dahlen G H, Guyton J R, Mohammad A, Farmer J A, Kautz J A, Gotto A M. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–65
   PubMed Web of Science ®Google Scholar
• Rhoads G G, Dahlen G, Berg K, Morton N E. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540–4
   PubMed Web of Science ®Google Scholar
• Jurgens G, Koltringer P. Lipoprotein (a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. Neurology 1987; 37: 513–5
   PubMed Web of Science ®Google Scholar
• Zenker G, Koltringer P, Bon G, Niederkorn K, Pfeiffer K, Jurgens G. Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 1986; 17: 942–5
   PubMedGoogle Scholar
• Boerwinkle E, Leffert C C, Lin J R, Lackner C, Chiesa G, Hobbs H H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52–60
   PubMed Web of Science ®Google Scholar
• Wiklund O, Angelin B, Olofsson S O, et al. Apolipo-protein(a) and ischaemic heart disease in familial hyper-cholesterolaemia. Lancet 1990; 335: 1360–3
   PubMed Web of Science ®Google Scholar
• Soutar A K, McCarthy S N, Seed M, Knight B L. Relationship between apolipoprotein(a) phenotype, lipoprotein (a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664→leu mutation in the LDL-receptor gene. J Clin Invest 1991; 88: 483–92
   PubMedGoogle Scholar
• Elisaf M, Bairaktari H, Siamopoulos K C. Lp(a) levels in Greek patients with heterozygous familial hypercholesterolemia. Int J Cardiol 1996; 53: 314–6
   PubMed Web of Science ®Google Scholar
• Bartens W, Rader D J, Talley G, Brewer H B, Jr. Lipoprotein (a) in patients with hyperfipidaemia. Eur J Clin Invest 1995; 25: 647–53
   PubMedGoogle Scholar
• Hiraga T, Okubo M, Kobayashi T, Nakanishi K, Sugimoto T, Murase T. Serum lipoprotein (a) levels differ in different phenotypes of primary hyperlipoproteinemia. Metabolism 1993; 42: 1327–30
   PubMedGoogle Scholar
• Ritter M M, Geiss H C, Richter W O, Schwandt P. Lipoprotein (a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia. Metabolism 1994; 43: 572–8
   PubMed Web of Science ®Google Scholar
• Friedewald W T, Levy Rl, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 409–502
   Google Scholar
• Silerman S R, Armentrout M A, Vella F A, Saha A L. MACRA (TM) Lp(a) for quantitation of human lipoprotein (a) enzyme linked immunoassay. Clin Chem 1990; 36: 961, (Abstr)
   Google Scholar
• Dahlen G H, Guyton J R, Attar H, Farmer J A, Kautz J A, Goko A M. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–65
   PubMed Web of Science ®Google Scholar
• Mbewu A D, Bahatnagar O, Durrington P N, et al. Serum lipoprotein (a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control population. Arterioscler Thromb 1991; 11: 940–6
   PubMedGoogle Scholar
• Hofmann S L, Eaton D L, Brown M S, McConathy W J, Goldstein J L, Hammer R E. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest 1990; 85: 1542–7
   PubMed Web of Science ®Google Scholar
• Brewer H B. Effectiveness of diet and drugs in the treatment of patients with elevated Lp(a) levels. Lipoprotein (a), A M Scanu. Academic Press, New York 1990; 211–20
   Google Scholar
• Ghiselli G, Gaddi A, Barozzi G, Ciarrocchi A, Descovich G. Plasma lipoprotein (a) concentration in familial hyper-cholesterolemic patients without coronary heart disease. Metabolism 1992; 41: 833–8
   PubMedGoogle Scholar
• Werba J P, Safa O, Gianfranceschi G, Michelagnoli S, Sirtori C R, Franceschini G. Plasma triglycerides and lipoprotein(a), inverse relationship in a hyperlipidemic Italian population. Atherosclerosis 1993; 101: 203–11
   PubMedGoogle Scholar
• Bartens W, Rader D J, Talley G, Brewer H B, Jr. Decreased plasma levels of lipoprotein (a) in patients with hypertriglyceridemia. Atherosclerosis 1994; 108: 149–57
   PubMed Web of Science ®Google Scholar
• Zechner R, Desoye G, Schenditsch M O, Pfeiffer K P, Kostner G M. Fluctuations of plasma lipoprotein (a) concentrations during pregnancy and post partum. Metabolism 1986; 35: 333–6
   PubMed Web of Science ®Google Scholar
• Farmer J A, Ballantyne C M, Frazier O H, et al. Lipoprotein(a) and apolipoprotein changes after cardiac transplantation. J Am Coll Cardiol 1991; 18: 926–30
   PubMedGoogle Scholar
• McConathy W J, Trieu V N, Klor H U, Corder C N. Lp(a) and plasma triglyceride-rich lipoproteins. Klin Wochenschr 1990; 68: 117–9
   PubMedGoogle Scholar
• Reblin T, Rader D J, Beisiegel U, Greten H, Brewer H B, Jr. Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma. Atherosclerosis 1992; 94: 223–32
   PubMedGoogle Scholar
• Bersot T P, Innerarity T L, Pitas R E, Rail S C, Jr, Weisgraber K H, Mahley R W. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein(a) and that cause lipid accumulation in macrophages. J Clin Invest 1986; 77: 622–30
   PubMedGoogle Scholar
• Pfaffinger D, Schülke J, Kim C, Fless G M, Scanu A M. Relation between apo(a) isoforms and Lp(a) density in subjects with different apo(a) phenotype: a study before and after a fatty meal. J Lipid Res 1991; 32: 679–83
   PubMedGoogle Scholar
• Scanu A M, Pfaffinger D, Edelstein C. Postpradial Lp(a), identification of a triglyceride-rich particle containing apoE. Chem Phys Lipids 1994; 67/68: 193–8
   Google Scholar
• Morrisett J, Gaubatz J, Nana M, . Metabolism of apo(a) and apo-B 100 in human lipoprotein(a). Drugs Affecting Lipid Metabolism, A L Catapano, A M Gotto, Jr, L C Smith, R Paoletti, et al. Kluwer Academic Publishers, DordrechtThe Netherlands 1993; 161–7
   Google Scholar
• Marcovina S M, Morrisett J D. Structure and metabolism of lipoprotein (a). Curr Opin Lipidol 1995; 6: 136–45
   PubMedGoogle Scholar
• Kreisberg R A. Low high-density lipoprotein cholesterol: what does it mean, what can we do about it, and what should we do about it?. Am J Med 1993; 94: 1–6
   PubMedGoogle Scholar